vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and Eightco Holdings Inc. (ORBS). Click either name above to swap in a different company.
Eightco Holdings Inc. is the larger business by last-quarter revenue ($10.2M vs $7.8M, roughly 1.3× CRYO CELL INTERNATIONAL INC). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -2281.6%, a 2232.9% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -49.9%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-11.0M). Over the past eight quarters, Eightco Holdings Inc.'s revenue compounded faster (13.1% CAGR vs -0.1%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
CCEL vs ORBS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $10.2M |
| Net Profit | $-3.8M | $-232.5M |
| Gross Margin | 77.9% | -13.0% |
| Operating Margin | -50.6% | -475.0% |
| Net Margin | -48.7% | -2281.6% |
| Revenue YoY | -2.3% | -49.9% |
| Net Profit YoY | -105.1% | -9183.3% |
| EPS (diluted) | $-0.46 | $-2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $10.2M | ||
| Q3 25 | $7.8M | $5.3M | ||
| Q2 25 | $7.9M | $7.6M | ||
| Q1 25 | $8.0M | $9.9M | ||
| Q4 24 | $8.0M | $20.3M | ||
| Q3 24 | $8.1M | $6.1M | ||
| Q2 24 | $8.0M | $5.3M | ||
| Q1 24 | $7.9M | $8.0M |
| Q4 25 | $-3.8M | $-232.5M | ||
| Q3 25 | $749.4K | $-25.8M | ||
| Q2 25 | $355.8K | $-1.2M | ||
| Q1 25 | $282.9K | $-2.5M | ||
| Q4 24 | $-1.9M | $-2.5M | ||
| Q3 24 | $1.1M | $-3.2M | ||
| Q2 24 | $655.8K | $4.4M | ||
| Q1 24 | $556.2K | $1.9M |
| Q4 25 | 77.9% | -13.0% | ||
| Q3 25 | 77.0% | -3.7% | ||
| Q2 25 | 76.6% | 16.4% | ||
| Q1 25 | 75.1% | 8.2% | ||
| Q4 24 | 78.4% | 8.2% | ||
| Q3 24 | 73.6% | 26.5% | ||
| Q2 24 | 74.8% | 25.1% | ||
| Q1 24 | 73.7% | 17.5% |
| Q4 25 | -50.6% | -475.0% | ||
| Q3 25 | 24.3% | -116.9% | ||
| Q2 25 | 18.8% | -15.9% | ||
| Q1 25 | 13.3% | -14.3% | ||
| Q4 24 | -1.5% | -11.9% | ||
| Q3 24 | 17.2% | -29.1% | ||
| Q2 24 | 17.3% | -16.4% | ||
| Q1 24 | 10.5% | -39.6% |
| Q4 25 | -48.7% | -2281.6% | ||
| Q3 25 | 9.6% | -487.6% | ||
| Q2 25 | 4.5% | -15.4% | ||
| Q1 25 | 3.5% | -25.7% | ||
| Q4 24 | -23.2% | -12.3% | ||
| Q3 24 | 13.0% | -52.5% | ||
| Q2 24 | 8.2% | 84.2% | ||
| Q1 24 | 7.1% | 24.4% |
| Q4 25 | $-0.46 | $-2.34 | ||
| Q3 25 | $0.09 | $-0.58 | ||
| Q2 25 | $0.04 | $-0.38 | ||
| Q1 25 | $0.03 | $-0.84 | ||
| Q4 24 | $-0.23 | $-1.44 | ||
| Q3 24 | $0.13 | $-1.77 | ||
| Q2 24 | $0.08 | $2.15 | ||
| Q1 24 | $0.07 | $1.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $58.5M |
| Total DebtLower is stronger | $8.4M | — |
| Stockholders' EquityBook value | $-18.6M | $232.6M |
| Total Assets | $61.7M | $250.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $58.5M | ||
| Q3 25 | $3.2M | $23.7M | ||
| Q2 25 | $4.4M | $696.3K | ||
| Q1 25 | $3.5M | $434.4K | ||
| Q4 24 | $3.5M | $239.2K | ||
| Q3 24 | $2.1M | $2.4M | ||
| Q2 24 | $1.5M | $363.1K | ||
| Q1 24 | $979.6K | $808.8K |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | $232.6M | ||
| Q3 25 | $-14.8M | $339.2M | ||
| Q2 25 | $-15.6M | $8.9M | ||
| Q1 25 | $-14.7M | $9.7M | ||
| Q4 24 | $-13.2M | $11.9M | ||
| Q3 24 | $-9.6M | $13.0M | ||
| Q2 24 | $-10.7M | $13.8M | ||
| Q1 24 | $-10.3M | $3.9M |
| Q4 25 | $61.7M | $250.2M | ||
| Q3 25 | $63.2M | $355.5M | ||
| Q2 25 | $64.4M | $48.7M | ||
| Q1 25 | $64.4M | $47.6M | ||
| Q4 24 | $64.7M | $50.8M | ||
| Q3 24 | $62.9M | $49.2M | ||
| Q2 24 | $62.6M | $48.4M | ||
| Q1 24 | $61.7M | $50.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $-11.0M |
| Free Cash FlowOCF − Capex | $1.2M | $-11.0M |
| FCF MarginFCF / Revenue | 15.5% | -107.7% |
| Capex IntensityCapex / Revenue | 0.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $-11.0M | ||
| Q3 25 | $2.5M | $-1.6M | ||
| Q2 25 | $707.0K | $-659.2K | ||
| Q1 25 | $954.1K | $999.8K | ||
| Q4 24 | $2.2M | $-6.6M | ||
| Q3 24 | $2.4M | $77.7K | ||
| Q2 24 | $1.8M | $-440.3K | ||
| Q1 24 | $-356.9K | $-723.3K |
| Q4 25 | $1.2M | $-11.0M | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $644.6K | $-661.3K | ||
| Q1 25 | $892.0K | $999.7K | ||
| Q4 24 | $2.1M | $-6.6M | ||
| Q3 24 | $2.3M | $73.0K | ||
| Q2 24 | $21.5K | — | ||
| Q1 24 | $-814.6K | — |
| Q4 25 | 15.5% | -107.7% | ||
| Q3 25 | 31.9% | — | ||
| Q2 25 | 8.1% | -8.7% | ||
| Q1 25 | 11.2% | 10.1% | ||
| Q4 24 | 26.8% | -32.7% | ||
| Q3 24 | 27.9% | 1.2% | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | -10.4% | — |
| Q4 25 | 0.9% | 0.0% | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 0.8% | 0.0% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 2.3% | 0.1% | ||
| Q2 24 | 21.8% | — | ||
| Q1 24 | 5.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | -0.10× | ||
| Q1 24 | -0.64× | -0.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
